Chemotherapy-Induced Collagen IV Drives Cancer Cell Motility through Activation of Src and Focal Adhesion Kinase

Triple-negative breast cancer (TNBC) is the most aggressive and deadly subtype of breast cancer, accounting for 30,000 cases annually in the United States. While there are several clinical trials ongoing to identify new agents to treat TNBC, the majority of patients with TNBC are treated with anthra...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatherree, Jackson P., Guarin, Justinne R., McGinn, Rachel A., Naber, Stephen P., Oudin, Madeleine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Convergence and Technologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381104/
https://www.ncbi.nlm.nih.gov/pubmed/35260882
http://dx.doi.org/10.1158/0008-5472.CAN-21-1823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381104/
https://www.ncbi.nlm.nih.gov/pubmed/35260882
http://dx.doi.org/10.1158/0008-5472.CAN-21-1823

Ejemplares similares